Klor-Con-Ef (Potassium Bicarbonate/Cit Ac) Patent Expiration, LOE Window & CMS Spending

Klor-Con-Ef (Potassium Bicarbonate/Cit Ac) by Upsher-Smith La: Off-Patent Genericized (AB Competition), 0 AB generics, $453K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorUpsher-Smith La
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$453K
2024 Medicare Part D Spend$311K
2024 Medicaid Spend$142K
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel